Cargando…

The modified Glasgow prognostic score in prostate cancer: results from a retrospective clinical series of 744 patients

BACKGROUND: As the incidence of prostate cancer continues to rise steeply, there is an increasing need to identify more accurate prognostic markers for the disease. There is some evidence that a higher modified Glasgow Prognostic Score (mGPS) may be associated with poorer survival in patients with p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shafique, Kashif, Proctor, Michael J, McMillan, Donald C, Leung, Hing, Smith, Karen, Sloan, Billy, Morrison, David S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3686580/ https://www.ncbi.nlm.nih.gov/pubmed/23768149 http://dx.doi.org/10.1186/1471-2407-13-292

Ejemplares similares

Systemic Inflammation Predicts All-Cause Mortality: A Glasgow Inflammation Outcome Study
por: Proctor, Michael J., et al.
Publicado: (2015)

An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study
por: Proctor, M J, et al.
Publicado: (2011)

The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome Study
por: Proctor, M J, et al.
Publicado: (2010)

Coffee consumption and prostate cancer risk: further evidence for inverse relationship
por: Shafique, Kashif, et al.
Publicado: (2012)

Cholesterol and the risk of grade-specific prostate cancer incidence: evidence from two large prospective cohort studies with up to 37 years' follow up
por: Shafique, Kashif, et al.
Publicado: (2012)

Glasgow prognostic score is a better predictor of the long-term survival in patients with gastric cancer, compared to the modified Glasgow prognostic score or high-sensitivity modified Glasgow prognostic score
por: Hirahara, Noriyuki, et al.
Publicado: (2020)

The high-sensitivity modified Glasgow prognostic score is superior to the modified Glasgow prognostic score as a prognostic predictor for head and neck cancer
por: Hanai, Nobuhiro, et al.
Publicado: (2018)

Glasgow Prognostic Score and modified Glasgow Prognostic Score and survival in patients with hepatocellular carcinoma: a meta-analysis
por: Lu, Lingling, et al.
Publicado: (2021)

Reply: Glasgow Prognostic Score as a predictive factor differentiating surgical site infection and remote infection following colorectal cancer surgery?
por: Moyes, L, et al.
Publicado: (2009)

Validation of a modified clinical risk score to predict cancer-specific survival for stage II colon cancer
por: Oliphant, Raymond, et al.
Publicado: (2015)

Clinical utility of the Glasgow Prognostic Score in patients undergoing curative nephrectomy for renal clear cell cancer: basis of new prognostic scoring systems
por: Lamb, G W A, et al.
Publicado: (2012)

The preoperative sensitive-modified Glasgow prognostic score is superior to the modified Glasgow prognostic score in predicting long-term survival for esophageal squamous cell carcinoma
por: Tian, Rui, et al.
Publicado: (2016)

Modified Glasgow Prognostic Score is Better for Predicting Oncological Outcome in Patients with Soft Tissue Sarcoma, Compared to High-Sensitivity Modified Glasgow Prognostic Score
por: Nakamura, Tomoki, et al.
Publicado: (2022)

Staging the Tumor and Staging the Host: Pretreatment Combined Neutrophil Lymphocyte Ratio and Modified Glasgow Prognostic Score Is Associated with Overall Survival in Patients with Esophagogastric Cancers Undergoing Treatment with Curative Intent
por: McSorley, Stephen T., et al.
Publicado: (2020)

External validation of the modified Glasgow prognostic score for renal cancer
por: Tai, Caroline G., et al.
Publicado: (2014)

Socio-Economic Inequalities in Survival of Patients with Prostate Cancer: Role of Age and Gleason Grade at Diagnosis
por: Shafique, Kashif, et al.
Publicado: (2013)

A Meta-Analysis of Glasgow Prognostic Score and Modified Glasgow Prognostic Score as Biomarkers for Predicting Survival Outcome in Renal Cell Carcinoma
por: Tong, Tongyu, et al.
Publicado: (2020)

744 Integrative Nursing framework in Burn ICU
por: Thomas, Mini, et al.
Publicado: (2022)

744 Characteristics of Verified and Designated Burn Centers
por: Carter, Jeffrey, et al.
Publicado: (2023)

Utility of the High-Sensitivity Modified Glasgow Prognostic Scores for Oropharyngeal Carcinoma
por: Iuchi, Hiroyuki, et al.
Publicado: (2021)

Prognostic Value of High-Sensitivity Modified Glasgow Prognostic Score in Castration-Resistant Prostate Cancer Patients Who Received Docetaxel
por: Ando, Keisuke, et al.
Publicado: (2021)

Utility of the Modified and High-Sensitivity Modified Glasgow Prognostic Scores for Hypopharyngeal Squamous Cell Carcinoma
por: Iuchi, Hiroyuki, et al.
Publicado: (2021)

The prognostic value of modified Glasgow Prognostic Score in pancreatic cancer: a meta-analysis
por: Zhang, Huan, et al.
Publicado: (2020)

Oncogenic miR-744 promotes prostate cancer growth through direct targeting of LKB1
por: Zhang, Minglei, et al.
Publicado: (2019)

A comprehensive analysis of Glasgow Prognostic Score (GPS)/the modified Glasgow Prognostic Score (mGPS) on immune checkpoint inhibitor efficacy among patients with advanced cancer
por: Zhang, Yongchao, et al.
Publicado: (2022)

Comparison of tumour-based (Petersen Index) and inflammation-based (Glasgow Prognostic Score) scoring systems in patients undergoing curative resection for colon cancer
por: Roxburgh, C S D, et al.
Publicado: (2009)

Clinical utility of the modified Glasgow prognostic score in lung cancer: A meta-analysis
por: Jin, Jing, et al.
Publicado: (2017)

The modified Glasgow prognostic score in Crohn’s disease—does it predict short-term outcome?
por: Argeny, Stanislaus, et al.
Publicado: (2018)

Prognostic Value of the Modified Glasgow Prognostic Score in Patients Undergoing Radical Surgery for Hepatocellular Carcinoma
por: Ni, Xiao-Chun, et al.
Publicado: (2015)

The modified glasgow prognostic score is an independent prognostic indicator in neoadjuvantly treated adenocarcinoma of the esophagogastric junction
por: Jomrich, Gerd, et al.
Publicado: (2018)

Prognostic Significance of the Modified Glasgow Prognostic Score in Patients With Pancreatic Cancer: A Meta-Analysis
por: Fu, Wen, et al.
Publicado: (2020)

MicroRNA-744 promotes prostate cancer progression through aberrantly activating Wnt/β-catenin signaling
por: Guan, Han, et al.
Publicado: (2017)

Exam ref 70-744: securing Windows Server 2016
por: Warner, Timothy L, et al.
Publicado: (2017)

Correction to Lancet Rheumatol 2021; 3: e744–47
Publicado: (2022)

The Glasgow Microenvironment Score and risk and site of recurrence in TNM I–III colorectal cancer
por: Alexander, P. G., et al.
Publicado: (2022)

Post-Transcriptional Regulation of Transforming Growth Factor Beta-1 by MicroRNA-744
por: Martin, John, et al.
Publicado: (2011)

The Glasgow Microenvironment Score associates with prognosis and adjuvant chemotherapy response in colorectal cancer
por: Alexander, Peter G., et al.
Publicado: (2020)

The Modified Glasgow Prognostic Score as a Predictor of Survival After Hepatectomy for Colorectal Liver Metastases
por: Nakagawa, Kazuya, et al.
Publicado: (2014)

Biliary drainage improves the predictive value of modified Glasgow Prognostic Scores in inoperable pancreatic cancer
por: Iino, Chikara, et al.
Publicado: (2017)

The inflammation‐based modified Glasgow prognostic score is associated with survival in stable heart failure patients
por: Cho, Anna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_11c9t4tmtrqjfak6emm4n3o2dm